A.I. is critical to the growth of healthcare in the coming decade. It needs to be managed correctly and urgent ethical guidelines regulating its use need to be implimented.
Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.
